Clinical trial
A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg…
NCT00002054 · Fisons, Industry · Completed
Key facts
| NCT number | NCT00002054 |
|---|---|
| Title | A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients |
| Official title | A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients |
| Lead sponsor | Fisons, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Pneumonia, Pneumocystis Carinii, HIV Infections |
| Intervention type | Drug |
| Interventions | Pentamidine isethionate |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: